• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人类多能干细胞和肾祖细胞再生肾脏。

Regenerating the kidney using human pluripotent stem cells and renal progenitors.

机构信息

a Nephrology and Dialysis Unit , Meyer Children's University Hospital , Florence , Italy.

b Department of Biomedical Experimental and Clinical Sciences "Mario Serio" , University of Florence , Florence , Italy.

出版信息

Expert Opin Biol Ther. 2018 Jul;18(7):795-806. doi: 10.1080/14712598.2018.1492546. Epub 2018 Jul 9.

DOI:10.1080/14712598.2018.1492546
PMID:29939787
Abstract

INTRODUCTION

Chronic kidney disease is a major health-care problem worldwide and its cost is becoming no longer affordable. Indeed, restoring damaged renal structures or building a new kidney represents an ambitious and ideal alternative to renal replacement therapy. Streams of research have explored the possible application of pluripotent stem cells (SCs) (embryonic SCs and induced pluripotent SCs) in different strategies aimed at regenerate functioning nephrons and at understanding the mechanisms of kidney regeneration.

AREAS COVERED

In this review, we will focus on the main potential applications of human pluripotent SCs to kidney regeneration, including those leading to rebuilding new kidneys or part of them (organoids, scaffolds, biological microdevices) as well as those aimed at understanding the pathophysiological mechanisms of renal disease and regenerative processes (modeling of kidney disease, genome editing). Moreover, we will discuss the role of endogenous renal progenitors cells in order to understand and promote kidney regeneration, as an attractive alternative to pluripotent SCs.

EXPERT OPINION

Opportunities and pitfalls of all these strategies will be underlined, finally leading to the conclusion that a deeper knowledge of the biology of pluripotent SCs is mandatory, in order to allow us to hypothesize their clinical application.

摘要

简介

慢性肾脏病是全球范围内的一个主要医疗保健问题,其成本已变得难以承受。事实上,修复受损的肾脏结构或构建新的肾脏,代表了一种替代肾脏替代疗法的有抱负和理想的替代方案。许多研究探索了多能干细胞(SCs)(胚胎干细胞和诱导多能干细胞)在不同策略中的可能应用,旨在再生有功能的肾单位,并了解肾脏再生的机制。

涵盖领域

在这篇综述中,我们将重点关注人类多能干细胞在肾脏再生中的主要潜在应用,包括那些旨在重建新肾脏或其部分(类器官、支架、生物微器件)的应用,以及旨在理解肾脏疾病和再生过程的病理生理机制的应用(肾脏疾病建模、基因组编辑)。此外,我们将讨论内源性肾脏祖细胞在理解和促进肾脏再生中的作用,作为多能干细胞的一种有吸引力的替代方法。

专家意见

所有这些策略的机遇和陷阱都将被强调,最终得出的结论是,为了使我们能够假设其临床应用,必须深入了解多能干细胞的生物学。

相似文献

1
Regenerating the kidney using human pluripotent stem cells and renal progenitors.利用人类多能干细胞和肾祖细胞再生肾脏。
Expert Opin Biol Ther. 2018 Jul;18(7):795-806. doi: 10.1080/14712598.2018.1492546. Epub 2018 Jul 9.
2
Regenerative strategies for kidney engineering.肾脏工程的再生策略。
FEBS J. 2016 Sep;283(18):3303-24. doi: 10.1111/febs.13704. Epub 2016 Mar 24.
3
[Breakthrough in research on pluripotent stem cells and their application in medicine].[多能干细胞研究突破及其在医学中的应用]
Laeknabladid. 2015 Dec;101(12):581-6. doi: 10.17992/lbl.2015.12.56.
4
Report on ISN Forefronts, Florence, Italy, 12-15 September 2013: Stem cells and kidney regeneration.2013 年 9 月 12 日至 15 日,意大利佛罗伦萨 ISN 前沿会议报告:干细胞与肾脏再生。
Kidney Int. 2014 Jul;86(1):23-7. doi: 10.1038/ki.2014.32. Epub 2014 Jun 4.
5
Regenerative potential of induced pluripotent stem cells derived from patients undergoing haemodialysis in kidney regeneration.血液透析患者诱导多能干细胞在肾脏再生中的再生潜能。
Sci Rep. 2018 Oct 8;8(1):14919. doi: 10.1038/s41598-018-33256-7.
6
Kidney regeneration from human induced pluripotent stem cells.从人类诱导多能干细胞再生肾脏。
Curr Opin Organ Transplant. 2015 Apr;20(2):171-7. doi: 10.1097/MOT.0000000000000170.
7
Concise Review: Kidney Generation with Human Pluripotent Stem Cells.简明综述:人类多能干细胞生成肾脏。
Stem Cells. 2017 Nov;35(11):2209-2217. doi: 10.1002/stem.2699. Epub 2017 Sep 26.
8
In vitro regeneration of kidney from pluripotent stem cells.多能干细胞诱导的肾体外再生。
Exp Cell Res. 2010 Oct 1;316(16):2571-7. doi: 10.1016/j.yexcr.2010.04.034. Epub 2010 May 6.
9
Cell therapy for kidney injury: different options and mechanisms--kidney progenitor cells.肾损伤的细胞治疗:不同选择与机制——肾祖细胞
Nephron Exp Nephrol. 2014;126(2):64. doi: 10.1159/000360668. Epub 2014 May 19.
10
Cell reprogramming: a new chemical approach to stem cell biology and tissue regeneration.细胞重编程:干细胞生物学和组织再生的新化学方法。
Curr Pharm Biotechnol. 2011 Feb 1;12(2):146-50. doi: 10.2174/138920111794295828.

引用本文的文献

1
Unveiling spontaneous renal tubule-like structures from human adult renal progenitor cell spheroids derived from urine.从尿液来源的成人肾祖细胞球体中揭示自发形成的肾小管样结构。
Stem Cells Transl Med. 2025 Mar 18;14(3). doi: 10.1093/stcltm/szaf002.
2
Current strategies on kidney regeneration using tissue engineering approaches: a systematic review.利用组织工程方法进行肾脏再生的当前策略:一项系统综述。
BMC Nephrol. 2025 Feb 11;26(1):66. doi: 10.1186/s12882-025-03968-w.
3
Targeting necroptosis in fibrosis.靶向纤维化中的细胞坏死性凋亡。
Mol Biol Rep. 2023 Dec;50(12):10471-10484. doi: 10.1007/s11033-023-08857-9. Epub 2023 Nov 1.
4
Defining diagnostic trajectories in patients with podocytopathies.定义足细胞病患者的诊断轨迹。
Clin Kidney J. 2022 May 3;15(11):2006-2019. doi: 10.1093/ckj/sfac123. eCollection 2022 Nov.
5
Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis.干细胞来源的细胞外囊泡作为原发性和继发性肾小球肾炎治疗策略的新进展。
Int J Mol Sci. 2022 May 20;23(10):5760. doi: 10.3390/ijms23105760.
6
Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease.间充质干细胞衍生的外泌体:迈向慢性肾脏病的无细胞治疗策略
Front Med (Lausanne). 2022 Mar 21;9:816656. doi: 10.3389/fmed.2022.816656. eCollection 2022.
7
Adipose-Derived Stem/Stromal Cells in Kidney Transplantation: Status Quo and Future Perspectives.脂肪来源的干细胞/基质细胞在肾移植中的应用:现状与未来展望。
Int J Mol Sci. 2021 Oct 17;22(20):11188. doi: 10.3390/ijms222011188.
8
Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis.干细胞治疗肾纤维化:肾纤维化发病机制的临床前和临床研究综述。
Stem Cell Res Ther. 2021 Jun 10;12(1):333. doi: 10.1186/s13287-021-02391-w.
9
Molecular Mechanisms of Renal Progenitor Regulation: How Many Pieces in the Puzzle?肾脏祖细胞调控的分子机制:拼图中有多少块?
Cells. 2021 Jan 2;10(1):59. doi: 10.3390/cells10010059.
10
Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease.人诱导多能干细胞和肾祖细胞在实验性慢性肾脏病中的治疗潜力。
Stem Cell Res Ther. 2020 Dec 9;11(1):530. doi: 10.1186/s13287-020-02060-4.